vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and STEM, INC. (STEM). Click either name above to swap in a different company.
STEM, INC. is the larger business by last-quarter revenue ($47.1M vs $31.1M, roughly 1.5× LIFECORE BIOMEDICAL, INC. \DE\). LIFECORE BIOMEDICAL, INC. \DE\ runs the higher net margin — -32.1% vs -33.9%, a 1.8% gap on every dollar of revenue. On growth, LIFECORE BIOMEDICAL, INC. \DE\ posted the faster year-over-year revenue change (-4.5% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
LFCR vs STEM — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $47.1M |
| Net Profit | $-10.0M | $-16.0M |
| Gross Margin | 25.0% | 48.9% |
| Operating Margin | -9.9% | -17.7% |
| Net Margin | -32.1% | -33.9% |
| Revenue YoY | -4.5% | -15.6% |
| Net Profit YoY | -52.0% | 68.8% |
| EPS (diluted) | $-0.29 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $47.1M | ||
| Q3 25 | $31.1M | $38.2M | ||
| Q2 25 | — | $38.4M | ||
| Q1 25 | $35.2M | $32.5M | ||
| Q4 24 | $32.6M | $55.8M | ||
| Q3 24 | $24.7M | $29.3M | ||
| Q2 24 | — | $34.0M | ||
| Q1 24 | $35.7M | $25.5M |
| Q4 25 | — | $-16.0M | ||
| Q3 25 | $-10.0M | $-23.8M | ||
| Q2 25 | — | $202.5M | ||
| Q1 25 | $-14.8M | $-25.0M | ||
| Q4 24 | $-6.6M | $-51.1M | ||
| Q3 24 | $-16.2M | $-148.3M | ||
| Q2 24 | — | $-582.3M | ||
| Q1 24 | $15.6M | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | 25.0% | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | 28.0% | 32.4% | ||
| Q4 24 | 34.0% | -4.4% | ||
| Q3 24 | 21.8% | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | 33.3% | -95.0% |
| Q4 25 | — | -17.7% | ||
| Q3 25 | -9.9% | -33.6% | ||
| Q2 25 | — | -34.8% | ||
| Q1 25 | -25.7% | -65.0% | ||
| Q4 24 | -6.0% | -84.4% | ||
| Q3 24 | -46.9% | -493.2% | ||
| Q2 24 | — | -1705.5% | ||
| Q1 24 | -2.5% | -267.0% |
| Q4 25 | — | -33.9% | ||
| Q3 25 | -32.1% | -62.2% | ||
| Q2 25 | — | 527.8% | ||
| Q1 25 | -42.0% | -76.9% | ||
| Q4 24 | -20.2% | -91.6% | ||
| Q3 24 | -65.7% | -506.3% | ||
| Q2 24 | — | -1712.6% | ||
| Q1 24 | 43.8% | -283.9% |
| Q4 25 | — | $-4.40 | ||
| Q3 25 | $-0.29 | $-2.84 | ||
| Q2 25 | — | $-1.79 | ||
| Q1 25 | $-0.47 | $-0.15 | ||
| Q4 24 | $-0.25 | $-15.29 | ||
| Q3 24 | $-0.53 | $-18.24 | ||
| Q2 24 | — | $-71.81 | ||
| Q1 24 | $0.42 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $48.9M |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $-249.4M |
| Total Assets | $235.2M | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $48.9M | ||
| Q3 25 | $18.9M | $43.1M | ||
| Q2 25 | — | $40.8M | ||
| Q1 25 | $5.4M | $58.6M | ||
| Q4 24 | $9.5M | $56.3M | ||
| Q3 24 | — | $75.4M | ||
| Q2 24 | — | $89.6M | ||
| Q1 24 | — | $112.8M |
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | — |
| Q4 25 | — | $-249.4M | ||
| Q3 25 | $-10.5M | $-235.7M | ||
| Q2 25 | — | $-214.1M | ||
| Q1 25 | $2.2M | $-417.5M | ||
| Q4 24 | $15.4M | $-398.4M | ||
| Q3 24 | $-3.9M | $-344.1M | ||
| Q2 24 | — | $-203.2M | ||
| Q1 24 | $17.7M | $371.6M |
| Q4 25 | — | $308.9M | ||
| Q3 25 | $235.2M | $362.6M | ||
| Q2 25 | — | $379.2M | ||
| Q1 25 | $237.7M | $405.1M | ||
| Q4 24 | $255.4M | $437.4M | ||
| Q3 24 | $246.8M | $537.8M | ||
| Q2 24 | — | $691.5M | ||
| Q1 24 | $246.2M | $1.3B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $8.2M |
| Free Cash FlowOCF − Capex | $25.0K | — |
| FCF MarginFCF / Revenue | 0.1% | — |
| Capex IntensityCapex / Revenue | 5.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.2M | ||
| Q3 25 | $1.8M | $11.4M | ||
| Q2 25 | — | $-21.3M | ||
| Q1 25 | $1.2M | $8.5M | ||
| Q4 24 | $-6.1M | $-14.7M | ||
| Q3 24 | $-613.0K | $-9.4M | ||
| Q2 24 | — | $-11.9M | ||
| Q1 24 | $-1.4M | $-621.0K |
| Q4 25 | — | — | ||
| Q3 25 | $25.0K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-4.3M | — | ||
| Q4 24 | $-8.6M | — | ||
| Q3 24 | $-4.0M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-7.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -12.1% | — | ||
| Q4 24 | -26.3% | — | ||
| Q3 24 | -16.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -21.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 15.5% | — | ||
| Q4 24 | 7.5% | — | ||
| Q3 24 | 13.9% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 17.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
STEM
Segment breakdown not available.
